[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100395621":3},{"organization":4,"armGroups":7,"interventions":17,"overallOfficials":39,"centralContacts":44,"locations":50,"responsibleParty":177,"collaborators":179,"id":183,"slug":184,"hasResults":185,"nctId":186,"briefTitle":187,"officialTitle":188,"acronym":10,"eligibilityCriteria":189,"healthyVolunteers":185,"sex":190,"minAge":191,"maxAge":10,"enrollmentInfo":192,"targetDuration":10,"studyType":195,"phases":10,"briefSummary":196,"conditions":197,"keywords":10,"overallStatus":67,"whyStopped":10,"lastUpdateSubmitDate":199,"lastUpdatePostDateStruct":200,"startDateStruct":203,"completionDateStruct":205,"leadSponsor":207,"locationsCount":208},{"fullName":5,"class":6},"Fred Hutchinson Cancer Center","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Observational (questionnaire, biospecimen, chart review)",null,"Patients complete questionnaires over 10 minutes about physical symptoms, activity level, and emotional well-being and have their medical records reviewed at baseline, 1, 3, and 6 months after starting index treatment, and at start of a new systemic treatment. Patients also undergo collection of blood samples over 1-2 minutes at baseline and at 1 month after starting index treatment, or at a treatment change visit if new therapy has not started.",[13,14,15,16],"Procedure: Biospecimen Collection","Other: Medical Chart Review","Other: Quality-of-Life Assessment","Other: Questionnaire Administration",[18,23,29,35],{"type":19,"name":20,"description":21,"armGroupLabels":22,"otherNames":10},"PROCEDURE","Biospecimen Collection","Undergo collection of blood sample",[9],{"type":6,"name":24,"description":25,"armGroupLabels":26,"otherNames":27},"Medical Chart Review","Review of medical chart",[9],[28],"Chart Review",{"type":6,"name":30,"description":31,"armGroupLabels":32,"otherNames":33},"Quality-of-Life Assessment","Ancillary studies",[9],[34],"Quality of Life Assessment",{"type":6,"name":36,"description":37,"armGroupLabels":38,"otherNames":10},"Questionnaire Administration","Complete questionnaire",[9],[40],{"name":41,"affiliation":42,"role":43},"Stephanie J. Lee","Fred Hutch\u002FUniversity of Washington Cancer Consortium","PRINCIPAL_INVESTIGATOR",[45],{"name":46,"role":47,"phone":48,"phoneExt":10,"email":49},"Gaby Desatnik","CONTACT","206-667-1356","cgvhd@fredhutch.org",[51,65,81,97,107,117,133,143,153,165],{"facility":52,"status":53,"city":54,"state":55,"zip":56,"country":57,"countryCode":58,"cosmosGeoPoint":59,"geoPoint":64,"contacts":10},"University of Florida","COMPLETED","Gainesville","Florida","32610","United States","US",{"type":60,"coordinates":61},"Point",[62,63],-82.32483,29.65163,{"lat":63,"lon":62},{"facility":66,"status":67,"city":68,"state":55,"zip":69,"country":57,"countryCode":58,"cosmosGeoPoint":70,"geoPoint":74,"contacts":75},"Moffitt Cancer Center","RECRUITING","Tampa","33612",{"type":60,"coordinates":71},[72,73],-82.45843,27.94752,{"lat":73,"lon":72},[76,80],{"name":77,"role":47,"phone":78,"phoneExt":10,"email":79},"Joseph Pidala","888-663-3488","Joseph.Pidala@moffitt.org",{"name":77,"role":43,"phone":10,"phoneExt":10,"email":10},{"facility":82,"status":67,"city":83,"state":84,"zip":85,"country":57,"countryCode":58,"cosmosGeoPoint":86,"geoPoint":90,"contacts":91},"Dana-Farber Harvard Cancer Center","Boston","Massachusetts","02115",{"type":60,"coordinates":87},[88,89],-71.05977,42.35843,{"lat":89,"lon":88},[92,96],{"name":93,"role":47,"phone":94,"phoneExt":10,"email":95},"Corey S. Cutler","617-632-5946","corey_cutler@dfci.harvard.edu",{"name":93,"role":43,"phone":10,"phoneExt":10,"email":10},{"facility":98,"status":53,"city":99,"state":100,"zip":101,"country":57,"countryCode":58,"cosmosGeoPoint":102,"geoPoint":106,"contacts":10},"University of Minnesota\u002FMasonic Cancer Center","Minneapolis","Minnesota","55455",{"type":60,"coordinates":103},[104,105],-93.26384,44.97997,{"lat":105,"lon":104},{"facility":108,"status":53,"city":109,"state":110,"zip":111,"country":57,"countryCode":58,"cosmosGeoPoint":112,"geoPoint":116,"contacts":10},"Roswell Park Cancer Institute","Buffalo","New York","14263",{"type":60,"coordinates":113},[114,115],-78.87837,42.88645,{"lat":115,"lon":114},{"facility":118,"status":67,"city":119,"state":120,"zip":121,"country":57,"countryCode":58,"cosmosGeoPoint":122,"geoPoint":126,"contacts":127},"Cleveland Clinic Foundation","Cleveland","Ohio","44195",{"type":60,"coordinates":123},[124,125],-81.69541,41.4995,{"lat":125,"lon":124},[128,132],{"name":129,"role":47,"phone":130,"phoneExt":10,"email":131},"Betty K. Hamilton","216-444-6833","HAMILTB2@ccf.org",{"name":129,"role":43,"phone":10,"phoneExt":10,"email":10},{"facility":134,"status":53,"city":135,"state":136,"zip":137,"country":57,"countryCode":58,"cosmosGeoPoint":138,"geoPoint":142,"contacts":10},"UPMC Hillman Cancer Center","Pittsburgh","Pennsylvania","15232",{"type":60,"coordinates":139},[140,141],-79.99589,40.44062,{"lat":141,"lon":140},{"facility":144,"status":53,"city":145,"state":146,"zip":147,"country":57,"countryCode":58,"cosmosGeoPoint":148,"geoPoint":152,"contacts":10},"Vanderbilt University\u002FIngram Cancer Center","Nashville","Tennessee","37232",{"type":60,"coordinates":149},[150,151],-86.78444,36.16589,{"lat":151,"lon":150},{"facility":42,"status":67,"city":154,"state":155,"zip":156,"country":57,"countryCode":58,"cosmosGeoPoint":157,"geoPoint":161,"contacts":162},"Seattle","Washington","98109",{"type":60,"coordinates":158},[159,160],-122.33207,47.60621,{"lat":160,"lon":159},[163,164],{"name":46,"role":47,"phone":48,"phoneExt":10,"email":49},{"name":41,"role":43,"phone":10,"phoneExt":10,"email":10},{"facility":166,"status":53,"city":167,"state":168,"zip":169,"country":170,"countryCode":171,"cosmosGeoPoint":172,"geoPoint":176,"contacts":10},"Vancouver General Hospital\u002FBC Cancer","Vancouver","British Columbia","V5Z 4E6","Canada","CA",{"type":60,"coordinates":173},[174,175],-123.11934,49.24966,{"lat":175,"lon":174},{"type":178,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[180],{"name":181,"class":182},"National Cancer Institute (NCI)","NIH","100395621","predicting-the-quality-of-response-to-specific-treatments-in-patients-with-cgvhd-pqrst-study-100395621",false,"NCT04431479","Predicting the Quality of Response to Specific Treatments in Patients With cGVHD, PQRST Study","Predicting the Quality of Response to Specific Treatments (PQRST)","Inclusion Criteria:\n\n* Adults age 18 or older\n* Prior allogeneic stem cell transplant, with any graft source, donor type, and GVHD prophylaxis\n* No evidence of persistent or progressive malignancy at the time of enrollment\n* Agrees to be evaluated at the transplant center before a new line of treatment is started (may be concurrent with the enrollment visit), and later between 2-6 weeks, 3 months and 6 months after index treatment is started or if an additional new therapy is started before 6 months\n* Signed, informed consent\n\nExclusion Criteria:\n\n* Inability to comply with study procedures\n* Uncontrolled psychiatric disorder\n* Anticipated survival \\\u003C 6 months","ALL","18 Years",{"count":193,"type":194},300,"ESTIMATED","OBSERVATIONAL","This trial collects clinical data and blood samples to predict the quality of response to specific treatments in patients with chronic graft-versus-host disease (cGVHD) who are about to start a new therapy. Collecting and analyzing clinical data and blood samples from patients with cGVHD before and after treatment initiation may help doctors identify changes that may predict treatment response.",[198],"Chronic Graft Versus Host Disease","2026-05-18",{"date":201,"type":202},"2026-05-20","ACTUAL",{"date":204,"type":202},"2020-06-29",{"date":206,"type":194},"2027-07-01",{"name":5,"class":6},10]